Optima Medical Innovations Corp.
TOKIF · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 3/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.01 | -0.00 | 54.12 |
| FCF Yield | -3.59% | -40.28% | -16.30% | -0.07% |
| EV / EBITDA | -3.41 | -0.51 | -0.78 | -3,780.13 |
| Quality | ||||
| ROIC | -34.28% | -84.02% | -39.51% | -2.05% |
| Gross Margin | 29.93% | -76.15% | -844.48% | 63.86% |
| Cash Conversion Ratio | 0.08 | 0.12 | 0.10 | 0.50 |
| Growth | ||||
| Revenue 3-Year CAGR | 87.95% | 1,878.06% | 932.67% | – |
| Free Cash Flow Growth | 87.53% | -31.11% | -413.64% | -267.75% |
| Safety | ||||
| Net Debt / EBITDA | -0.43 | -0.13 | 0.07 | -0.62 |
| Interest Coverage | -3.07 | -32.24 | -1,166.26 | -2.01 |
| Efficiency | ||||
| Inventory Turnover | 1,541.63 | 595.73 | 53.73 | 0.00 |
| Cash Conversion Cycle | -97.42 | -37.99 | 204.39 | 170,705.60 |